Article By:
MoneyShow.com
Saturday, December 9, 2023 12:05 AM EDT
Biotech stocks are still in the process of repairing the damage from recent months — and recent years. Indeed, as of a month ago, the SPDR Biotech Fund had been dead money for an unbelievable eight and a half years